Topical treatment of the burn patient.
The pathophysiology, classification and bacteriology of burns are discussed, as well as treatment of burns with silver nitrate, silver sulfadizine, silver allantoinate, mafenide acetate, furazolium chloride, povidone-iodine complex, antibiotics, antiproteolytics, fibrinolytics, Pseudomonas vaccine and antiglobulins.
D000287:Administration, Topical; D000481:Allantoin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000888:Antibodies, Anti-Idiotypic / Q000627:therapeutic use; D002056:Burns / Q000188:drug therapy* / Q000503:physiopathology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy; D008528:Mefenamic Acid / Q000627:therapeutic use; D009581:Nitrofurans / Q000627:therapeutic use; D011206:Povidone-Iodine / Q000627:therapeutic use; D011480:Protease Inhibitors; D011549:Pseudomonas; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use; D012835:Silver Nitrate / Q000627:therapeutic use; D013411:Sulfadiazine / Q000627:therapeutic use; D013844:Thiazoles; D014946:Wound Infection / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D000888:Antibodies, Anti-Idiotypic; D004791:Enzyme Inhibitors; D005343:Fibrinolytic Agents; D009581:Nitrofurans; D011480:Protease Inhibitors; D000644:Quaternary Ammonium Compounds; D013844:Thiazoles; D013411:Sulfadiazine; D000481:Allantoin; D008528:Mefenamic Acid; C007800:furazolium chloride; D011206:Povidone-Iodine; D012835:Silver Nitrate